Sandra A. Jacobson

Clinical Laboratory Medicine for Mental Health Professionals

Sandra A. Jacobson

A revised, abridged version of the seminal work, Laboratory Medicine in Psychiatry and Behavioral Science, Clinical Laboratory Medicine for Mental Health Professionals more directly address the needs of general psychiatrists and their mental health colleagues in clinical practice.Sections on laboratory tests, diseases and conditions, and psychotropic medications include alphabetically arranged entries, making it easy for busy clinicians to reference the updated information. For each laboratory test, the following information is provided: The type of test (e.g., blood, urine, etc.) An explanation of the test The test's relevance to psychiatry Patient preparation Medical and psychiatric indications for the test Numerical reference ranges Critical values for test results The potential meaning of abnormal results (e.g., factors that lead to increased or decreased levels) Interfering factors Cross-references to other tests or conditions Information on clinical diagnosis and laboratory testing is provided for diseases and conditions, and psychotropic medications are examined from both a screening and a monitoring standpoint. Extensively indexed, this guide also includes an appendix that features at-a-glance information on therapeutic and psychotropic levels, 10 rules for deciding whether an ECG is normal, and several figures covering topics relevant to tests, such as ECG waves and intervals, cholestatic injury, bilirubin cycle, and SIADH secretion.Years of clinical practice and research inform both the choice of tests included and the rationale for their use, making Clinical Laboratory Medicine for Mental Health Professionals the definitive, authoritative reference for psychiatrists and other behavioral health clinicians.

Clinical Manual of Geriatric Psychopharmacology

Sandra A. Jacobson

In the 7 years since the first edition of Clinical Manual of Geriatric Psychopharmacology was published, dozens of new drugs have been released, and older medications have been marketed in different formulations. In addition, research on pharmacokinetics, pharmacodynamics and mechanism of action, potential interactions, and other critical topics has proceeded apace, rendering much of the information in existing guides obsolete. This new volume is both comprehensive and completely up to date, offering information unavailable elsewhere. New drugs covered include asenapine, paliperidone, iloperidone, lurasidone, desvenlafaxine, vilazodone, long-acting trazodone, milnacipran, armodafinil, extended-release valproate, rotigotine transdermal, tetrabenazine, dextromethorphan, long-acting gabapentin, and transdermal buprenorphine. Each chapter has a standardized format, with topics including pharmacokinetics, pharmacodynamics and mechanism of action, drug interactions, clinical use (which addresses choice of drug, alternative formulations/routes, pre-treatment evaluation, dose and dose titration, PRN use, monitoring treatment, drug levels, managing treatment resistance, switching drugs, duration of treatment, discontinuation, and overdose), adverse effects, and treatment of selected syndromes and disorders. Dozens of tables, boxes, and figures organize and present complex material, such as practice guidelines, in a straightforward manner that is easy to understand and apply, and the concise, bulleted text facilitates reading and comprehension in the clinical setting. «Specific Drug Summaries» – one-page summaries of prescribing information for individual drugs – provide fast access to critical information in a simple format. Designed for residents, fellows, and all clinicians in psychiatry and medicine who diagnose and treat psychiatric and neuropsychiatric conditions affecting geriatric patients, this clinical reference can be used across all treatment settings (inpatient, outpatient, day hospital, consultation, and nursing home). Meticulously referenced and grounded in the latest research, Clinical Manual of Geriatric Psychopharmacology, Second Edition, is the definitive guide to psychotropic use in elderly patients. Clinicians can rely confidently on its up-to-date coverage and authoritative counsel.